rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1-2
|
pubmed:dateCreated |
2007-7-30
|
pubmed:abstractText |
To investigate whether differences in plasma pharmacokinetic profiles of gefitinib between healthy subjects having normal (N; t(1/2)>20h) and altered (A; t(1/2)<20h) pharmacokinetic (PK) profiles might be explained by inter-individual variability in gastric emptying and/or precipitation/dissolution of gefitinib in the proximal small intestine.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0378-5173
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
16
|
pubmed:volume |
341
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
134-42
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:17482782-Administration, Oral,
pubmed-meshheading:17482782-Adult,
pubmed-meshheading:17482782-Antineoplastic Agents,
pubmed-meshheading:17482782-Chemical Precipitation,
pubmed-meshheading:17482782-Crystallization,
pubmed-meshheading:17482782-Gastric Emptying,
pubmed-meshheading:17482782-Half-Life,
pubmed-meshheading:17482782-Humans,
pubmed-meshheading:17482782-Intestinal Secretions,
pubmed-meshheading:17482782-Intubation, Gastrointestinal,
pubmed-meshheading:17482782-Jejunum,
pubmed-meshheading:17482782-Male,
pubmed-meshheading:17482782-Microscopy,
pubmed-meshheading:17482782-Middle Aged,
pubmed-meshheading:17482782-Protein Kinase Inhibitors,
pubmed-meshheading:17482782-Quinazolines,
pubmed-meshheading:17482782-Reference Values,
pubmed-meshheading:17482782-Solubility,
pubmed-meshheading:17482782-Spectrum Analysis, Raman
|
pubmed:year |
2007
|
pubmed:articleTitle |
Pharmacokinetics of gefitinib in humans: the influence of gastrointestinal factors.
|
pubmed:affiliation |
Department of Pharmacy, Uppsala University, Box 580, 751 23 Uppsala, Sweden.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't
|